Head and Neck Cancer
FEATURES
avatar
1681 clinical trials
avatar
0 cell line models
avatar
8 approved drugs
IMAGE
Head and Neck Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

8 drugs have received FDA approval for Head and Neck Cancer:

  • Amifostine
  • Bleomycin Sulfate
  • Cetuximab
  • Docetaxel
  • Hydroxyurea
More

282 drugs have a clinical trial registered for Head and Neck Cancer.

1159 compounds have been tested in Head and Neck Cancer (767 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 1681 clinical trials for Head and Neck Cancer, 919 of which have one or more drug interventions, 762 with no drug intervention.
Cell line models

There are 0 Cell Line Models for Head and Neck Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Head and Neck Cancer:
  • Head and Neck Neoplasms
  • Squamous Cell Carcinoma of Head and Neck
  • Facial Neoplasms
The following terms have been mapped from cancer.gov to Head and Neck Cancer:
  • Squamous cell carcinoma of the head and neck (SCCHN)
  • Squamous cell carcinoma of the head and neck (excluding the lip) that is locally advanced. It is used with chemoradiation
  • Squamous cell carcinoma of the head and neck that is:Local or advanced. It is used with radiation therapy
  • Xerostomia (dry mouth). It is used to decrease dryness in the mouth caused by radiation therapy after surgery in some patients with head and neck cancer
  • Squamous cell carcinoma of the head and neck that has metastasized or recurred (come back) in patients whose disease got worse during or after treatment with platinum chemotherapy.????
More